Class information for:
Level 1: IRON OVERLOAD//DEFERASIROX//THALASSEMIA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
928 2954 33.0 73%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
332 3       ERYTHROPOIETIN//ANEMIA//FERRITIN 37752
210 2             IRON OVERLOAD//HEPCIDIN//HEMOCHROMATOSIS 20783
928 1                   IRON OVERLOAD//DEFERASIROX//THALASSEMIA 2954

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IRON OVERLOAD authKW 2128789 20% 36% 579
2 DEFERASIROX authKW 1423772 7% 71% 195
3 THALASSEMIA authKW 1190786 15% 26% 436
4 DEFERIPRONE authKW 856024 5% 56% 149
5 IRON CHELATION THERAPY authKW 641860 3% 82% 76
6 THALASSEMIA MAJOR authKW 522500 4% 44% 114
7 IRON CHELATION authKW 413128 4% 32% 126
8 BETA THALASSEMIA MAJOR authKW 297323 2% 43% 67
9 THALASSAEMIA authKW 294596 3% 28% 103
10 DEFERIPRONE L1 authKW 258112 1% 78% 32

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 66863 46% 0% 1351
2 Pediatrics 2864 12% 0% 341
3 Radiology, Nuclear Medicine & Medical Imaging 1576 10% 0% 297
4 Medicine, General & Internal 523 8% 0% 230
5 Oncology 442 8% 0% 249
6 Cardiac & Cardiovascular System 423 6% 0% 177
7 Transplantation 324 3% 0% 76
8 Medical Laboratory Technology 163 1% 0% 44
9 Medicine, Research & Experimental 122 4% 0% 107
10 Peripheral Vascular Diseases 65 2% 0% 64

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MICROCITEMIA 185258 1% 81% 22
2 THALASSEMIA 150828 2% 21% 69
3 CA GRANDA FDN IRCCS 142224 1% 81% 17
4 THALASSEMIA UNIT 140630 1% 39% 35
5 ANEMIE CONGENITE 133342 1% 65% 20
6 THALASSAEMIA UNIT 99188 1% 40% 24
7 OSPED REG MICROCITEMIE 89848 1% 43% 20
8 UOS TALASSEMIA 82681 0% 100% 8
9 CMR UNIT 78464 1% 29% 26
10 IRCCS CA GRANDA FDN MAGGIORE POLICLIN HOSP 78320 0% 63% 12

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HEMOGLOBIN 35450 3% 4% 88
2 EUROPEAN JOURNAL OF HAEMATOLOGY 23836 3% 2% 94
3 ACTA HAEMATOLOGICA 15896 2% 2% 73
4 BRITISH JOURNAL OF HAEMATOLOGY 12811 4% 1% 130
5 AMERICAN JOURNAL OF HEMATOLOGY 11029 3% 1% 80
6 HEMATOLOGY 10793 1% 3% 32
7 ANNALS OF HEMATOLOGY 10393 2% 2% 61
8 PEDIATRIC HEMATOLOGY AND ONCOLOGY 8080 1% 2% 40
9 SEMINARS IN HEMATOLOGY 6235 1% 2% 34
10 JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 5702 2% 1% 45

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 IRON OVERLOAD 2128789 20% 36% 579 Search IRON+OVERLOAD Search IRON+OVERLOAD
2 DEFERASIROX 1423772 7% 71% 195 Search DEFERASIROX Search DEFERASIROX
3 THALASSEMIA 1190786 15% 26% 436 Search THALASSEMIA Search THALASSEMIA
4 DEFERIPRONE 856024 5% 56% 149 Search DEFERIPRONE Search DEFERIPRONE
5 IRON CHELATION THERAPY 641860 3% 82% 76 Search IRON+CHELATION+THERAPY Search IRON+CHELATION+THERAPY
6 THALASSEMIA MAJOR 522500 4% 44% 114 Search THALASSEMIA+MAJOR Search THALASSEMIA+MAJOR
7 IRON CHELATION 413128 4% 32% 126 Search IRON+CHELATION Search IRON+CHELATION
8 BETA THALASSEMIA MAJOR 297323 2% 43% 67 Search BETA+THALASSEMIA+MAJOR Search BETA+THALASSEMIA+MAJOR
9 THALASSAEMIA 294596 3% 28% 103 Search THALASSAEMIA Search THALASSAEMIA
10 DEFERIPRONE L1 258112 1% 78% 32 Search DEFERIPRONE+L1 Search DEFERIPRONE+L1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 PENNELL, DJ , UDELSON, JE , ARAI, AE , BOZKURT, B , COHEN, AR , GALANELLO, R , HOFFMAN, TM , KIERNAN, MS , LERAKIS, S , PIGA, A , ET AL (2013) CARDIOVASCULAR FUNCTION AND TREATMENT IN -THALASSEMIA MAJOR: A CONSENSUS STATEMENT FROM THE AMERICAN HEART ASSOCIATION.CIRCULATION. VOL. 128. ISSUE 3. P. 281 -308 203 74% 47
2 SALIBA, AN , EL RASSI, F , TAHER, AT , (2016) CLINICAL MONITORING AND MANAGEMENT OF COMPLICATIONS RELATED TO CHELATION THERAPY IN PATIENTS WITH BETA-THALASSEMIA.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 2. P. 151 -168 129 87% 1
3 HOFFBRAND, AV , TAHER, A , CAPPELLINI, MD , (2012) HOW I TREAT TRANSFUSIONAL IRON OVERLOAD.BLOOD. VOL. 120. ISSUE 18. P. 3657-3669 105 92% 41
4 WOOD, JC , (2015) ESTIMATING TISSUE IRON BURDEN: CURRENT STATUS AND FUTURE PROSPECTS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 170. ISSUE 1. P. 15 -28 83 86% 12
5 FISHER, SA , BRUNSKILL, SJ , DOREE, C , GOODING, S , CHOWDHURY, O , ROBERTS, DJ , (2013) DESFERRIOXAMINE MESYLATE FOR MANAGING TRANSFUSIONAL IRON OVERLOAD IN PEOPLE WITH TRANSFUSION-DEPENDENT THALASSAEMIA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - 98 87% 4
6 PORTER, JB , SHAH, FT , (2010) IRON OVERLOAD IN THALASSEMIA AND RELATED CONDITIONS: THERAPEUTIC GOALS AND ASSESSMENT OF RESPONSE TO CHELATION THERAPIES.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 24. ISSUE 6. P. 1109 -+ 95 90% 19
7 FISHER, SA , BRUNSKILL, SJ , DOREE, C , CHOWDHURY, O , GOODING, S , ROBERTS, DJ , (2013) ORAL DEFERIPRONE FOR IRON CHELATION IN PEOPLE WITH THALASSAEMIA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - 80 93% 2
8 TZIOMALOS, K , PERIFANIS, V , (2010) LIVER IRON CONTENT DETERMINATION BY MAGNETIC RESONANCE IMAGING.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 16. ISSUE 13. P. 1587-1597 102 76% 16
9 OLIVIERI, NF , BRITTENHAM, GM , (1997) IRON-CHELATING THERAPY AND THE TREATMENT OF THALASSEMIA.BLOOD. VOL. 89. ISSUE 3. P. 739 -761 111 60% 603
10 POGGIALI, E , CASSINERIO, E , ZANABONI, L , CAPPELLINI, MD , (2012) AN UPDATE ON IRON CHELATION THERAPY.BLOOD TRANSFUSION. VOL. 10. ISSUE 4. P. 411-422 72 89% 32

Classes with closest relation at Level 1


Rank Class id link
1 13647 THALASSEMIA MAJOR//THALASSEMIA//BETA THALASSEMIA MAJOR
2 16711 HYDROXYPYRIDINONE//3 HYDROXY 4 PYRIDINONES//3 HYDROXYPYRIDIN 4 ONE
3 29990 IRON POISONING//IRON OVERDOSE//IRON INTOXICATION
4 19183 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA
5 12918 IRON METAB CHELAT PROGRAM//PYRIDOXAL ISONICOTINOYL HYDRAZONE//MOL PHARMACOL PATHOL PROGRAM
6 24516 ASCORBIC ACID PALMITATE//HEPATOCELLULAR HEMOSIDEROSIS//COENZYME Q0
7 24198 BETA THALASSEMIA HEMOGLOBIN E//BETA THALASSEMIC//CD1A LYMPHOCYTE
8 27518 CHIMIOSENSIBIL PALUDISME//MULTIDENTATE AMINOTHIOLS//MEROZOITE RELEASE
9 36392 26 KDA HELICOBACTER SPECIES SPECIFIC ANTIGEN GENE//AMOL THALASSEMIA//CANCER ADVERSE EFFECTS
10 1983 HEMOCHROMATOSIS//HFE//HEREDITARY HEMOCHROMATOSIS

Go to start page